Haisco Pharma's HSK21542 Approved by NMPA for Post-Abdominal Surgery Pain
CompanyDrug

Haisco Pharma’s HSK21542 Approved by NMPA for Post-Abdominal Surgery Pain

Lifetech Scientific's Aortic Arch Stent System Approved by China's NMPA
CompanyMedical Device

Lifetech Scientific’s Aortic Arch Stent System Approved by China’s NMPA

Sihuan Pharmaceutical's Bireociclib Approved by NMPA for Advanced Breast Cancer
CompanyDrug

Sihuan Pharmaceutical’s Bireociclib Approved by NMPA for Advanced Breast Cancer

CANbridge's Velaglucerase β Approved by NMPA for Gaucher's Disease Long-Term Therapy
CompanyDrug

CANbridge’s Velaglucerase β Approved by NMPA for Gaucher’s Disease Long-Term Therapy

Merck KGaA and JD Health Launch Online Thyroid Care Center in China
CompanyDeals

Merck KGaA and JD Health Launch Online Thyroid Care Center in China

Novartis' Scemblix Approved by NMPA for Newly Diagnosed Ph+ CML-CP Patients
CompanyDrug

Novartis’ Scemblix Approved by NMPA for Newly Diagnosed Ph+ CML-CP Patients

AbbVie's Emrelis Granted FDA Accelerated Approval for NSCLC with High c-MET Overexpression
CompanyDrug

AbbVie’s Emrelis Granted FDA Accelerated Approval for NSCLC with High c-MET Overexpression

BeiGene Announces Plans to Relocate Headquarters to Switzerland from Cayman Islands
Company

BeiGene Announces Plans to Relocate Headquarters to Switzerland from Cayman Islands

Chengdu Kanghong's KH607 Approved for Clinical Trials in Postpartum Depression
CompanyDrug

Chengdu Kanghong’s KH607 Approved for Clinical Trials in Postpartum Depression

NMPA Releases Updated List of Medical Devices Exempted from Clinical Evaluation
Medical DevicePolicy / Regulatory

NMPA Releases Updated List of Medical Devices Exempted from Clinical Evaluation

Boehringer Ingelheim's Nerandomilast Filing Accepted for Review in Progressive Pulmonary Fibrosis
CompanyDrug

Boehringer Ingelheim’s Nerandomilast Filing Accepted for Review in Progressive Pulmonary Fibrosis

Novartis' Kisqali Receives NMPA Approval for High-Risk Early Breast Cancer
CompanyDrug

Novartis’ Kisqali Receives NMPA Approval for High-Risk Early Breast Cancer